Evidence map›Paper›PMID 35498334›Full record

ArticleRSC advances2020

Regioselective convergent synthesis of 2-arylidene thiazolo[3,2-

Mohamed Fares, Patrick M McCosker, Muhammad A Alsherbiny, Anthony C Willis, Timothy Clark, Johan Neyts, Dirk Jochmans, Paul A Keller

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohamed FaresSchool of Chemistry & Molecular Bioscience, Molecular Horizons, University of Wollongong, Illawarra Health & Medical Research Institute Wollongong NSW 2522 Australia Ph.fares@yahoo.com keller@uow.edu.au.ORCID https://orcid.org/0000-0003-0589-3955
Patrick M McCoskerSchool of Chemistry & Molecular Bioscience, Molecular Horizons, University of Wollongong, Illawarra Health & Medical Research Institute Wollongong NSW 2522 Australia Ph.fares@yahoo.com keller@uow.edu.au.ORCID https://orcid.org/0000-0003-0007-263X
Muhammad A AlsherbinyNICM Health Research Institute, Western Sydney University Westmead NSW 2145 Australia.ORCID https://orcid.org/0000-0001-9337-2441
Anthony C WillisResearch School of Chemistry, The Australian National University Canberra ACT 2601 Australia.
Timothy ClarkDepartment of Chemistry and Pharmacy, Computer-Chemistry-Center (CCC), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Nägelbachstrasse 25 91052 Erlangen Germany.ORCID https://orcid.org/0000-0001-7931-4659
Johan NeytsKU Leuven (University of Leuven), Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy B-3000 Leuven Belgium.ORCID https://orcid.org/0000-0002-0033-7514
Dirk JochmansKU Leuven (University of Leuven), Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy B-3000 Leuven Belgium.ORCID https://orcid.org/0000-0002-9265-6028
Paul A KellerSchool of Chemistry & Molecular Bioscience, Molecular Horizons, University of Wollongong, Illawarra Health & Medical Research Institute Wollongong NSW 2522 Australia Ph.fares@yahoo.com keller@uow.edu.au.ORCID https://orcid.org/0000-0003-4868-845X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Convergent and convenient regioselective synthesis of novel thiazolo[2,3-

Identifiers

PMID35498334
PMCPMC9049071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.